Yale Cancer Center Receives NCI Grant Renewal to Fund Clinical Trials
Yale Cancer Center/Smilow Cancer HospitalThe National Cancer Institute has awarded a UM1 grant renewal to Yale Cancer Center. The 6-year, $3 million a year grant will fund early phase investigator-initiated clinical trials to develop new potential therapies for treating both solid tumors and hematologic malignancies.